r 59022 has been researched along with interleukin-8 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gavioli, R; Lanza, F; Moretti, S; Reali, E; Spisani, S; Traniello, S | 1 |
| Chuang, CC; Kennedy, A; Kincaid, J; Marsh, A; Martinez, K; McIntosh, M; Reid, T; Shyamasundar, S | 1 |
2 other study(ies) available for r 59022 and interleukin-8
| Article | Year |
|---|---|
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils.
Topics: Adjuvants, Immunologic; Alkaloids; Anions; Antibody-Dependent Cell Cytotoxicity; Diacylglycerol Kinase; Humans; Interleukin-8; Neutrophil Activation; Neutrophils; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase C; Pyrimidinones; Respiratory Burst; Staurosporine; Superoxides; Thiazoles | 1995 |
Diacylglycerol kinase inhibitor R59022 attenuates conjugated linoleic acid-mediated inflammation in human adipocytes.
Topics: Adipocytes; Calcium; Cells, Cultured; Chemokine CCL2; Diacylglycerol Kinase; Enzyme Inhibitors; Humans; Inflammation; Interleukin-6; Interleukin-8; Linoleic Acids, Conjugated; Pyrimidinones; Thiazoles | 2013 |